Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Release of viral glycoproteins during Ebola virus infection.
Volchkov VE, Volchkova VA, Slenczka W, Klenk HD, Feldmann H. Volchkov VE, et al. Virology. 1998 May 25;245(1):110-9. doi: 10.1006/viro.1998.9143. Virology. 1998. PMID: 9614872
Crystal structure of the matrix protein VP40 from Ebola virus.
Dessen A, Volchkov V, Dolnik O, Klenk HD, Weissenhorn W. Dessen A, et al. Among authors: volchkov v. EMBO J. 2000 Aug 15;19(16):4228-36. doi: 10.1093/emboj/19.16.4228. EMBO J. 2000. PMID: 10944105 Free PMC article.
Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus.
Ruigrok RW, Schoehn G, Dessen A, Forest E, Volchkov V, Dolnik O, Klenk HD, Weissenhorn W. Ruigrok RW, et al. Among authors: volchkov v. J Mol Biol. 2000 Jun 30;300(1):103-12. doi: 10.1006/jmbi.2000.3822. J Mol Biol. 2000. PMID: 10864502
The Ebola virus VP35 protein functions as a type I IFN antagonist.
Basler CF, Wang X, Mühlberger E, Volchkov V, Paragas J, Klenk HD, García-Sastre A, Palese P. Basler CF, et al. Among authors: volchkov v. Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12289-94. doi: 10.1073/pnas.220398297. Proc Natl Acad Sci U S A. 2000. PMID: 11027311 Free PMC article.
Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection.
Reynard O, Mokhonov V, Mokhonova E, Leung J, Page A, Mateo M, Pyankova O, Georges-Courbot MC, Raoul H, Khromykh AA, Volchkov VE. Reynard O, et al. Among authors: volchkov ve. J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1060-5. doi: 10.1093/infdis/jir347. J Infect Dis. 2011. PMID: 21987742 Free PMC article.
Biosynthesis and role of filoviral glycoproteins.
Feldmann H, Volchkov VE, Volchkova VA, Ströher U, Klenk HD. Feldmann H, et al. Among authors: volchkov ve. J Gen Virol. 2001 Dec;82(Pt 12):2839-2848. doi: 10.1099/0022-1317-82-12-2839. J Gen Virol. 2001. PMID: 11714958 Review. No abstract available.
[Immunobiological properties of vp24 protein of Ebola virus expressed by recombinant vaccinia virus].
Chepurnov AA, Ternovoĭ VA, Dadaeva AA, Dmitriev IP, Sizikova LP, Volchkov VE, Kudoiarova NM, Rudzevich TN, Netesov SV. Chepurnov AA, et al. Among authors: volchkov ve. Vopr Virusol. 1997 May-Jun;42(3):115-20. Vopr Virusol. 1997. PMID: 9297340 Russian.
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases.
Volchkov VE, Becker S, Volchkova VA, Ternovoj VA, Kotov AN, Netesov SV, Klenk HD. Volchkov VE, et al. Virology. 1995 Dec 20;214(2):421-30. doi: 10.1006/viro.1995.0052. Virology. 1995. PMID: 8553543
Human asymptomatic Ebola infection and strong inflammatory response.
Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansoud-Soukate J, Capron M, Debré P, McCormick JB, Georges AJ. Leroy EM, et al. Among authors: volchkov ve. Lancet. 2000 Jun 24;355(9222):2210-5. doi: 10.1016/s0140-6736(00)02405-3. Lancet. 2000. PMID: 10881895
Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.
Volchkov VE, Volchkova VA, Muhlberger E, Kolesnikova LV, Weik M, Dolnik O, Klenk HD. Volchkov VE, et al. Science. 2001 Mar 9;291(5510):1965-9. doi: 10.1126/science.1057269. Epub 2001 Feb 1. Science. 2001. PMID: 11239157
71 results
Jump to page
Feedback